Search

Artificial intelligence (AI) is a rapidly advancing technology that has the potential to shape the future of optometry. AI can enhance diagnostic accuracy, identify diseases beyond eye care, increase practice efficiency, provide better treatments, and expand access to remote regions. Current AI tools, such as chatbots, are already changing how we work, but human expertise is still essential. AI has shown promise in disease diagnosis, with studies demonstrating higher sensitivity in detecting mild diabetic retinopathy compared to human assessment. Emerging capabilities include ambient listening and transcription technology, which can save time and improve documentation accuracy. AI is also being used to improve reading and functional vision capabilities for patients with advanced age-related macular degeneration (AMD), and to enhance color vision with AI-driven spectacle lenses. Ultimately, it is our ability to monitor and apply these advances in a patient-centered and efficient manner that will determine how AI shapes the future of eye care. [Extracted from the article]

The article critiques the impact of physician benefit managers (PBMs) on rising healthcare costs and the lack of transparency in their operations. Topics discussed include the conflict of interest and opacity of PBMs, the restrictive regulations affecting physician interactions with pharmaceutical companies, and the need for broader reform targeting the true sources of healthcare expenses.

The article informs about the importance of defining your values and thinking about your legacy in order to make decisions that align with your core beliefs and priorities. Topic include It also emphasizes the significance of setting specific goals, conducting a SWOT analysis, and envisioning your ideal future to create a fulfilling life and career. The article encourages readers to consider what legacy they want to leave behind and take steps to achieve it.

The article discusses ocular allergy management in the U.S. The author stated that correctly diagnosing and treating ocular allergies is an opportunity for optometrists to have an impact to their patients. In addition, the safe, ester-based steroid Alex is often viewed as a last resort despite proving to be safe. Moreover, aggressive treatment for VKC and AKC is warranted due to its potential of high long-term, sight-threatening complications.

The article presents guidelines for the diagnosis of lid margin disease (LMD). LMD is the root cause of many cases of dry eye, complaints of ocular discomfort and high contact lens dropout rates. Many eyecare practitioners overlook LMD because it looks familiar, patients complain later and LMD does not exist alone as a condition. Patients with LMD typically present with signs and symptoms consistent with dry eye.

The article focuses on the ocular health benefits of drinking red wine in moderation. It is stated that compounds found in red wine such as polyphenols may reduce the patients' chances of developing cataracts or age-related macular degeneration. Resveratrol, a polyphenol found in the grape skin, acts as an antioxidant that helps fight inflammation, inhibit oxidation of certain cells and prevent cell death.

A conference paper about the use of Laser-Assisted in situ Keratomileusis (LASIK) to treat dryness of the eye is presented. It mentions that dry eye is one of the most common side effects encountered by patients after undergoing LASIK. It discusses several theories which explain the reason behind the development of dry eye including neural feedback loop theory, goblet cell damage, change in corneal curvature, type of ablation and many others.

The article offers information on COVID-19 lockdowns have accelerated a trend that some of in eye care have long expected, which is that a growing number of patients prefer to make purchases online. Topics include the fact that COVID-19 shut down many eye care practices also made clear and should be focusing more attention on providing a seamless experience to patients, and visiting the brick-and-mortar practices or searching for products online.

The article offers a preview of the products and technology for the dry eye disease (DED) including the LipiView interferometer from TearScience, Lid Scrub Plus Platinum eyelid cleanser from OcuSoft and BlephEx, a new in-office procedure for treating dry eye and blepharitis.

The article offers information on the new technologies that are gracing a primary eye care office. Topics discussed include SightSync that can detect and measure eye alignment in less than two minutes, Ultrasound machine that can confirm a retinal detachment, assess axial length for cataract surgery and determine angle closure; and EyeKinetix that can determine the presence of relative afferent pupil defect (RAPD).

The article discusses dry eye and eye care. Topics include tear secretion, treatment for dry eyes and eye care providers (ECPs). Factors causing dry eye including use of digital devices, systemic diseases and aging population are mentioned. Other topics such as tear osmolarity, meibomian glands and routine check ups are also mentioned.

The article informs that innovative diagnostic testing and breakthrough therapies allow optometrists to focus on retinal disease and it works best when the optometrist takes the role of quarterback. We noted that optometrists make sure all members of the health care team are working in concert and at the top of their game, which ultimately benefits the patient.

The article discusses the trends in optometric practice. Topics mentioned include the need for optometry to have a game plan to address the threat of online or remote refraction to the patient's best interest, potential of optometric technology to improve the ability of optometrists to provide medical eye care for dry eye and keratoconus, and the approval of Avedro system for corneal collagen crosslinking by the U.S. Food and Drug Administration (FDA).

The article presents several innovations related to optometry with the potential to change eye care and the lives of patients. These include corneal collagen crosslinking procedure that offers nonsurgical strengthening of cornea for keratoconics. It notes the glaucoma therapy and drug delivery systems. It mentions the cataract surgery innovations and wearables and telemedicine.

The article focuses on a study related to placebo-controlled multicenter trial of eye cream HydroEye by researchers Stephen C. Pflugfelder and John D. sheppard. It mentions that the supplement included a source of fish oil, gama-linolenic acid (GLA), and docosahexaenoic acid. Also mentions about clinical research focused on combinations of eicosapentaenoic acid (EPA)/docosahexaenoic acid (DHA) and GLA.

The article discusses the approval process of generic drugs and their cost, efficacy, and safety in eye care. It says that generic drugs are required by the U.S. Food and Drug Administration (FDA) to be as safe and effective with the same active ingredient, dosage, and form as brand medications. It states that generic drugs consider an estimated cost of 500 million dollars to one billion dollars to go through development and FDA testing. Moreover, generic medications may cause complications.

The article focuses on the use of Femtosecond lasers for cataract surgery in the U.S. It mentions that femtosecond laser offers great potential for patients with cataracts since it creates incisions and exact capsulotomies in initiating a cataract procedure. It notes that the femtosecond technology is used to cut a laser-assisted in situ keratomileusis (LASIK) flap. Moreover, other ophthalmic applications include astigmatism correction, presbyopia correction, and lens bleaching.

The article evaluates several eye care products including the VMax SR from VMax Technologies, atLast! multifocal spectacle lenses and Electronics Lens Technology from Pixel Optics.

The article offers information about conjunctival chalasis or conjunctivochalasis, one known eye disease that is often confused with dry eye syndrome. Conjunctival chalasis is due to loose or redundant conjunctival tissue or the absence of subconjunctival tenons fascia. Its risks factors include advanced age, a history of dry eye, prior ocular surgery, and a history of conjunctival chemosis. Corticosteroids are suggested in treating conjunctival chalasis.

The article examines the existing research on accommodating intraocular lens (IOLs) and discusses how the latest technology works. It mentions that an accommodating IOL uses large haptics and a hinge on the optic to promote accommodative movement. It notes that the original Crystalens accommodating IOL was designed to move like the natural crystalline lenses. Patients who received the Crystallens HD did not experience diminished night vision quality when compared to standard monofocal IOLs.

The article cites various studies about the relationship between corneal staining and contact lens multipurpose solutions. One of the studies suggested that ReNu Multiplus solution was associated with the decrease of relative corneal sensitivity versus Opti-Free Express Lasting Comfort No Rib formula, in which the result shows no statistical difference between the solutions. Another study deals with the potential of Opti-Free Express than any other solution for ocular irritation.

The article investigates if conductive keratoplasty (CK) can improve near vision in postoperative laser assisted in situ keratomileusis (LASIK). The author stressed that as patients become presbyopic, KT meliorated the near visual sense after LASIK as revealed in the preliminary study. To give further light on the matter, several possible surgical options are presented to correct the problem.

The article presents information on a study related to lasik eye surgery. In the study, researchers reviewed eleven eyes of patients from clinics across the United States. The study indicates that increase in higher order aberrations might be an indicator of early keratoconus. In the study, the researchers findings suggest that a difference in cylinder between the two eyes or increasing cylinder is an early indicator of keratoconus. Researchers believe that all keratoconus begins on the posterior corneal surface.

The article relates that technological innovations have enhanced both optometric practice and vision care. It states that advances such as a refractor based on point spread function and electronic eyeglasses have made for improved and customized eye care. The article also narrates how the introduction of emPower electronic eyeglasses by PixelOptics/Panasonic Health Care which combine optics and electronics have empowered patients.